The arrival of preemptive psychiatry
Open accessThe DOI matches its Crossref record.
Abstract
Research over the past two decades has changed our understanding of mental disorders. Based on revolutionary technologies from genomics, imaging and neuroscience, mental disorders have become increasingly understood as brain disorders. Epidemiological and longitudinal studies have revealed that mental disorders are also developmental disorders, emerging while the brain is still developing and evolving often into a chronic and disabling course. While research has transformed our understanding of mental disorders, interventions have lagged behind. Treatments in 2007, like treatments in 1907, remain episodic and palliative. Yes, there are medications and psychosocial treatments of demonstrable efficacy in randomized clinical trials. But, the reality of treatments for schizophrenia, mood and anxiety disorders in 2007 is that: (a) most patients are better but not recovered (b) many patients are not responding to available treatments, and (c) many treatments are not accessible to those who need them. Lest one feel that this view is overly cynical, the outcome data for depression are not profoundly different from the results in many other chronic illnesses, such as hypertension and diabetes. The difference in psychiatry is that we expect less of our treatments. Antidepressants that relieve symptoms 40% after 6 weeks are considered ‘effective’ and antipsychotics that reduce the hallucinations but not the cognitive deficits of schizophrenia are labelled as a revolutionary ‘advance’ in treatment. Going forward, the vision of clinical care for psychiatry must resemble the vision of clinical care in the rest of medicine, best characterized as the 4P’s: participatory, personalized, predictive and preemptive. Participatory means that treatments are collaborative with patients and their families. The Internet has already opened up a world of medical information to the public. Patients and their families are better informed than ever before and increasingly prepared to participate in decisions about their care. Personalized means that treatments are selected based on individual needs. In contrast to efficacy trials that report results on groups of patients, we need outcomes that inform clinicians and patients about individual outcomes. In other words, we have evidence-based treatments, but we do not know whom those evidence-based treatments are for. Should a specific patient receive SSRIs or CBT? Who will develop metabolic syndrome on an atypical antipsychotic? Who will develop agranulocytosis on clozapine? Answers to these questions should allow clinicians to personalize care, optimizing current treatments. Predictive tools and preemptive medicine are our future. Predictive tools such as biomarkers are already in broad use in the rest of medicine. Genomic biomarkers for breast cancer risk or protein biomarkers for tracking relapse of prostate cancer are routine. While psychiatry does not yet have analogous tools, one can imagine that the next few years will yield a genomic biomarker to predict autism, an imaging biomarker to identify risk for schizophrenia, or a plasma protein predicting relapse of depression. Predictive tools will ultimately permit preemptive psychiatry, the most exciting vision for the future of our field. As noted above, current treatments are necessary but not sufficient. New treatments may yield greater palliative effects, but one can imagine that our best hope for a ‘cure’ for schizophrenia or autism or mood disorders will come from preemptive interventions. Of course, this is the recent history of coronary artery disease: prediction of risk based on plasma lipids and family history, early detection based on imaging, and preemption of myocardial infarction with stents, medication, and lifestyle changes. In the USA, NIH estimates that these and other life saving approaches have rescued nearly 1 million people who would have died of heart disease last year based on historical trends. One can only imagine how the same revolutionary technologies applied early in the prodrome of schizophrenia might preempt a first psychotic episode and reduce the morbidity of this chronic illness. Preempting schizophrenia will require not only early detection with reliable predictive tools, but also novel interventions that prevent or forestall psychosis. We do not know whether these interventions will be medications, psychosocial treatments, or some combination thereof. But we do know that the road to preventive interventions, like the road to any new direction in our field, will begin with a novel, exciting set of ideas. The publication of a new journal, Early Intervention in Psychiatry, dedicated to this topic is an important milestone for the field. This is the beginning of an exciting new direction for psychiatry, towards strategic interventions that promise even greater public health benefits than currently available treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O'Donovan, M., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,124
Self-citationEarly intervention in psychosis: concepts, evidence and future directions
MCGORRY, P. D., KILLACKEY, E., & YUNG, A. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00182.x · Cited by 581
“Ironically, however, since the early 1990s, this hitherto barren landscape has seen the growth of an increasingly rich harvest of evidence, and widespread national and international efforts for reform in services and treatment approaches, setting the scene for more serious efforts in early intervention in other mental…”
BackgroundAn Individualized Risk Calculator for Research in Prodromal Psychosis
Cannon, T. D., Yu, C., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Heinssen, R., Jeffries, C. D., Mathalon, D. H., McGlashan, T. H., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15070890 · Cited by 574
“Given limitations of current treatments for schizophrenia, with most patients showing substantial deficits in social and occupational functioning throughout life, there is considerable interest in developing preventive approaches to psychotic disorders (1).”
BackgroundTreasure, J., Stein, D., & Maguire, S. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12170 · Cited by 353
Green, J., Pickles, A., Pasco, G., Bedford, R., Wan, M. W., Elsabbagh, M., Slonims, V., Gliga, T., Jones, E., Cheung, C., et al. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12728 · Cited by 328
Metadata
- Authors
- Insel, T. R.
- Venue
- Early Intervention in Psychiatry
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 1
- Issue
- 1
- Pages
- 5-6
- ISSN
- 1751-7885 (ISSN-L)
- 1751-7893
- OpenAlex
- W2100444150
- Cited by
- 92
- References
- 0
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The arrival of preemptive psychiatry. https://app.cochat.ai/papers/10.1111/j.1751-7893.2007.00017.x
- The paper
- Insel, T. R. (2007). The arrival of preemptive psychiatry. Early Intervention in Psychiatry. https://doi.org/10.1111/j.1751-7893.2007.00017.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.